146 related articles for article (PubMed ID: 23734772)
1. Role of the eIF4E binding protein 4E-BP1 in regulation of the sensitivity of human pancreatic cancer cells to TRAIL and celastrol-induced apoptosis.
Chakravarthy R; Clemens MJ; Pirianov G; Perdios N; Mudan S; Cartwright JE; Elia A
Biol Cell; 2013 Sep; 105(9):414-29. PubMed ID: 23734772
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic tumours escape from translational control through 4E-BP1 loss.
Martineau Y; Azar R; Müller D; Lasfargues C; El Khawand S; Anesia R; Pelletier J; Bousquet C; Pyronnet S
Oncogene; 2014 Mar; 33(11):1367-74. PubMed ID: 23563181
[TBL] [Abstract][Full Text] [Related]
3. The 4E-BP1/eIF4E ratio is a determinant for rapamycin response in esophageal cancer cells.
Hsu HS; Lin MH; Jang YH; Kuo TT; Liu CC; Cheng TH
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):378-85. PubMed ID: 25439783
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the sensitivity of Jurkat T-cells to inhibition of protein synthesis by tumor necrosis factor α-related apoptosis-inducing ligand.
Elia A; Powley IR; MacFarlane M; Clemens MJ
J Interferon Cytokine Res; 2014 Oct; 34(10):769-77. PubMed ID: 24731196
[TBL] [Abstract][Full Text] [Related]
5. Macrophage inflammatory protein-1alpha and interferon-inducible protein 10 inhibit synergistically induced growth factor stimulation of MAP kinase activity and suppress phosphorylation of eukaryotic initiation factor 4E and 4E binding protein 1.
Aronica SM; Gingras AC; Sonenberg N; Cooper S; Hague N; Broxmeyer HE
Blood; 1997 May; 89(10):3582-95. PubMed ID: 9160663
[TBL] [Abstract][Full Text] [Related]
6. Phenethyl isothiocyanate, a cancer chemopreventive constituent of cruciferous vegetables, inhibits cap-dependent translation by regulating the level and phosphorylation of 4E-BP1.
Hu J; Straub J; Xiao D; Singh SV; Yang HS; Sonenberg N; Vatsyayan J
Cancer Res; 2007 Apr; 67(8):3569-73. PubMed ID: 17440067
[TBL] [Abstract][Full Text] [Related]
7. Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.
Musa J; Orth MF; Dallmayer M; Baldauf M; Pardo C; Rotblat B; Kirchner T; Leprivier G; Grünewald TG
Oncogene; 2016 Sep; 35(36):4675-88. PubMed ID: 26829052
[TBL] [Abstract][Full Text] [Related]
8. Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells.
Murtaza I; Saleem M; Adhami VM; Hafeez BB; Mukhtar H
Cancer Res; 2009 Feb; 69(3):1156-65. PubMed ID: 19176377
[TBL] [Abstract][Full Text] [Related]
9. Activation of p53 stimulates proteasome-dependent truncation of eIF4E-binding protein 1 (4E-BP1).
Constantinou C; Elia A; Clemens MJ
Biol Cell; 2008 May; 100(5):279-89. PubMed ID: 18021075
[TBL] [Abstract][Full Text] [Related]
10. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 4E-BP1 in the protection induced by HDLs on pancreatic beta-cells.
Pétremand J; Bulat N; Butty AC; Poussin C; Rütti S; Au K; Ghosh S; Mooser V; Thorens B; Yang JY; Widmann C; Waeber G
Mol Endocrinol; 2009 Oct; 23(10):1572-86. PubMed ID: 19574449
[TBL] [Abstract][Full Text] [Related]
12. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
13. Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11.
Dao P; Smith N; Scott-Algara D; Garbay C; Herbeuval JP; Chen H
Cancer Lett; 2015 Apr; 360(1):48-59. PubMed ID: 25684663
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein synthesis in apoptosis: differential requirements by the tumor necrosis factor alpha family and a DNA-damaging agent for caspases and the double-stranded RNA-dependent protein kinase.
Jeffrey IW; Bushell M; Tilleray VJ; Morley S; Clemens MJ
Cancer Res; 2002 Apr; 62(8):2272-80. PubMed ID: 11956083
[TBL] [Abstract][Full Text] [Related]
15. Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis.
Ryu BJ; Hwang MK; Park M; Lee K; Kim SH
Bioorg Med Chem Lett; 2012 Jun; 22(12):3862-5. PubMed ID: 22622069
[TBL] [Abstract][Full Text] [Related]
16. Modulation of 4E-BP1 function as a critical determinant of enzastaurin-induced apoptosis.
Dumstorf CA; Konicek BW; McNulty AM; Parsons SH; Furic L; Sonenberg N; Graff JR
Mol Cancer Ther; 2010 Dec; 9(12):3158-63. PubMed ID: 20971826
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
Mishra R; Miyamoto M; Yoshioka T; Ishikawa K; Matsumura Y; Shoji Y; Ichinokawa K; Itoh T; Shichinohe T; Hirano S; Kondo S
Int J Oncol; 2009 May; 34(5):1231-40. PubMed ID: 19360336
[TBL] [Abstract][Full Text] [Related]
18. Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency.
Li S; Sonenberg N; Gingras AC; Peterson M; Avdulov S; Polunovsky VA; Bitterman PB
Mol Cell Biol; 2002 Apr; 22(8):2853-61. PubMed ID: 11909977
[TBL] [Abstract][Full Text] [Related]
19. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
20. IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells.
Büneker CK; Yu R; Deedigan L; Mohr A; Zwacka RM
Cancer Lett; 2012 Mar; 316(2):168-77. PubMed ID: 22104728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
